Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 3, 2012, Pages 498-503

  Tsay, Feng Woei ^a   Tseng, Hui Hwa ^a   Hsu, Ping I ^a,c   Wang, Kai Ming ^a   Lee, Ching Chang ^a   Chang, Shiuh Nan ^a   Wang, Huay Min ^a   Yu, Hsien Chung ^a   Chen, Wen Chi ^a   Peng, Nan Jing ^a   Lai, Kwok Hung ^a   Wu, Deng Chyang ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Helicobacter pylori; Sequential therapy; Triple therapy

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; PANTOPRAZOLE; UREASE;

ABDOMINAL PAIN; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHEST TIGHTNESS; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEQUENTIAL THERAPY; TAIWAN; TASTE DISORDER; TRIPLE THERAPY; UREA BREATH TEST; XEROSTOMIA;

EID: 84863159130     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06885.x     Document Type: Article

References (35)

1. Suerbaum S, Michetti P. Helicobacter pylori infection. N. Engl. J. Med. 2002; 347: 1175-86.
2. Hunt RH, Lam SK. Helicobacter pylori: from art to a science. J. Gastroenterol. Hepatol. 1998; 13: 21-8.
3. Uemura N, Uemura N, Okamoto S etal. Helicobacter infection and the development of gastric cancer. N. Engl. J. Med. 2001; 345: 784-9.
4. Hsu PI, Lai KH, Lo GH etal. Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients. Gut 2002; 51: 15-20.
5. Malfertheiner P, Megraud F, O'Morain C etal. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-81.
6. Fock KM, Katelaris P, Sugano K etal. Second Asia-Pacific Conference. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J. Gastroenterol. Hepatol. 2009; 24: 1587-600.
7. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am. J. Gastroenterol. 2007; 102: 1808-25.
8. Laheij RJ, Rossum LG, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection-a meta-analysis. Aliment. Pharmacol. Ther. 1999; 13: 857-64.
9. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010; 59: 1143-53.
10. Rimbara E, Fischbach LA, Graham DY. Optimal therapy for Helicobacter pylori infections. Nat. Rev. Gastroenterol. Hepatol. 2011; 8: 79-88.
11. Gumurdulu Y, Serin E, Ozer B etal. Low eradication rate of Helicobacter pylori with triple 7-14days and quadruple therapy in Turkey. World J. Gastroenterol. 2004; 10: 668-71.
12. Bigard MA, Delchier JC, Riachi G, Thibault P, Barthelemy P. One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin. Aliment. Pharmacol. Ther. 1998; 12: 383-8.
13. Vakil N. Helicobacter pylori treatment: a practical approach [Editorial]. Am. J. Gastroenterol. 2006; 101: 497-9.
14. Megraud FH. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53: 1374-84.
15. De Francesco V, Giorgio F, Hassan C etal. A. worldwide H.pylori antibiotic resistance: a systematic review. J. Gastrointestin. Liver Dis. 2010; 19: 409-14.
16. Zullo A, Vaira D, Vakil N etal. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment. Pharmacol. Ther. 2003; 17: 719-26.
17. Gatta L, Vakil N, Leandro G, Di MF, Vaira D. Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. Am. J. Gastroenterol. 2009; 104: 3069-79.
18. Gisbert JP, Calvet X, O'connor A, Megraud F, O'Morain CA. Sequential therapy for Helicobacter pylori eradication: a critical review. J. Clin. Gastroenterol. 2010; 44: 313-25.
19. Jafri NS, Horning CA, Howden CW. Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naïve to treatment. Ann. Intern. Med. 2008; 148: 923-1.
20. Zullo A, De Francesco V, Hassan C, Morini S, Vaira D. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut 2007; 56: 1353-57.
21. Sanchez-Delgado J, Calvet X, Bujanda L etal. Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice. Am. J. Gastroenterol. 2008; 103: 2220-3.
22. Choi WH, Park DI, Oh SJ etal. Effectiveness of 10days sequential therapy for Helicobacter pylori eradication in Korea. Korean J. Gastroenterol. 2008; 51: 280-4.
23. Hsu PI, Lai KH, Lin CK etal. A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. Am. J. Gastroenterol. 2005; 100: 2378-92.
24. Hsu PI, Lai KH, Tseng HH etal. Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia. J. Clin. Gastroenterol. 1997; 25: 587-91.
25. Hsu PI, Lai KH, Chien EJ etal. Impact of bacterial eradication on the cell proliferation and p53 protein accumulation in Helicobacter pylori-associated gastritis. Anticancer Res. 2000; 20: 1221-8.
26. 13C urea breath test. Dig. Dis. Sci. 2001; 46: 1772-8.
27. Vaira D, Zullo A, Vakil N etal. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Ann. Intern. Med. 2007; 146: 556-63.
28. Uygun A, Kadayifci A, Yesilova Z etal. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia. Clin. Ther. 2008; 30: 528-34.
29. Hsu PI, Wu DC, Wu JY, Graham DY. Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14days? Helicobacter 2011; 16: 146-52.
30. Wu DC, Hsu PI, Wu JY etal. Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection. Clin. Gastroenterol. Hepatol. 2010; 8: 36-41.
31. Graham DY, Lu H, Yamaoka Y. Therapy for Helicobacter pylori infection can be improved : sequential therapy and beyond. Drugs 2008; 68: 725-36.
32. Sirimontaporn N, Thong-Ngam D, Tumwasorn S, Mahachai V. Ten-day sequential therapy of Helicobacter pylori infection in Thailand. Am. J. Gastroenterol. 2010; 1055: 1071-5.
33. Kwon JH, Lee DH, Song BJ etal. Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study. Helicobacter 2010; 15: 148-53.
34. Perri F, Villani MR, Festa V, Quitadamo M, Andriulli A. Predictors of failure of Helicobacter pylori with the standard "Masstricht triple therapy". Aliment. Phamacol. Ther. 2001; 15: 1023-9.
35. Liang SY, Mackowiak PA. Infections in the elderly. Clin. Geriatr. Med. 2007; 23: 441-56.